Xtant Medical Holdings, Inc.
XTNT- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001453593
No open-market purchases or sales by Xtant Medical Holdings, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $33.8M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Xtant Medical Holdings, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 21 | 20 | −1 |
| Shares | 74.5M | 82.7M | +8.21M (+11.0%) |
| Value | $175.8M | $134.8M | −$41.0M (−23.3%) |
New holders (3)
Institutions that held Xtant Medical Holdings, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Altium Capital Management LP | 8,292,602 | $13.5M | 3.14% |
| Virtu Financial LLC | 36,613 | $60.0K | 0.01% |
| State Street Corp | 22,800 | $37.0K | 0.00% |
Sold out (4)
Institutions that held Xtant Medical Holdings, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Marshall Wace, LLP | 47,559 | $112.0K |
| Millennium Management LLC | 11,786 | $28.0K |
| Barclays PLC | 2,951 | $7.00K |
| MBM Wealth Consultants, LLC | 33 | $0 |